Oxford Biomedica plc (LON:OXB)
London · Delayed Price · Currency is GBP · Price in GBX 571.00
-13.00 (-2.23%)
Jul 24, 2026, 5:12 PM GMT
Oxford Biomedica Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 168.74 | 128.8 | 89.54 | 139.99 | 142.8 | |
Revenue Growth (YoY) | 31.01% | 43.84% | -36.04% | -1.97% | 62.77% |
Cost of Revenue | 102.76 | 75.78 | 49.81 | 70.81 | 60.16 |
Gross Profit | 65.98 | 53.02 | 39.73 | 69.18 | 82.64 |
Selling, General & Admin | 43.72 | 35.78 | 30.8 | 28.22 | 15.15 |
Research & Development | 5.06 | 4.54 | 11.47 | 60.94 | 40.19 |
Other Operating Expenses | 39.68 | 52.08 | 181.63 | 10.24 | 6.53 |
Total Operating Expenses | 88.46 | 92.4 | 223.9 | 99.4 | 61.87 |
Operating Income | -22.48 | -39.38 | -184.17 | -30.22 | 20.77 |
Interest Income | 5.18 | 3.24 | 4.91 | 0.97 | - |
Interest Expense | -14.63 | -11.13 | -9.26 | -16.73 | -0.89 |
Total Non-Operating Income (Expense) | -9.45 | -7.89 | -4.35 | -15.76 | -0.89 |
Pretax Income | -31.94 | -47.27 | -188.53 | -45.98 | 19.88 |
Provision for Income Taxes | -1.29 | 1.34 | -4.37 | -0.82 | 0.87 |
Net Income | -30.65 | -48.61 | -184.16 | -45.16 | 19.01 |
Minority Interest in Earnings | -0.52 | -5.42 | -26.67 | -6 | - |
Net Income to Common | -30.13 | -43.19 | -157.49 | -39.16 | 19.01 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 112 | 103 | 97 | 95 | 83 |
Shares Outstanding (Diluted) | 112 | 103 | 97 | 95 | 83 |
Shares Change (YoY) | 8.18% | 7.15% | 1.82% | 13.59% | 4.43% |
EPS (Basic) | -0.27 | -0.42 | -1.63 | -0.41 | 0.23 |
EPS (Diluted) | -0.27 | -0.42 | -1.63 | -0.41 | 0.22 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -4.25 | -58.16 | -38.35 | -28.91 | 15.99 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.04 | -0.56 | -0.40 | -0.30 | 0.19 |
Gross Margin | 39.10% | 41.17% | 44.37% | 49.42% | 57.87% |
Operating Margin | -13.32% | -30.57% | -205.69% | -21.59% | 14.54% |
Profit Margin | -18.16% | -37.74% | -205.68% | -32.26% | 13.31% |
FCF Margin | -2.52% | -45.16% | -42.83% | -20.65% | 11.20% |
EBITDA | -2.64 | -16.95 | -155.46 | -3.86 | 33.22 |
EBITDA Margin | -1.56% | -13.16% | -173.63% | -2.76% | 23.27% |
EBIT | -22.48 | -39.38 | -184.17 | -30.22 | 20.77 |
EBIT Margin | -13.32% | -30.57% | -205.69% | -21.59% | 14.54% |
Effective Tax Rate | 4.04% | -2.84% | 2.32% | 1.78% | 4.37% |